| abstract |
A method to maintain induced remission of an immune disease has been disclosed, which can alleviate or reduce any serious side effects and pain suffered by a patient suffering from the disease. The method comprises carrying out the induction of the remission of an immune disease using a biological agent or a nucleic acid synthesis inhibitor agent and then using a sphingosine-l-phosphate receptor agonist in the patient. |